| 000 | 01388 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517074101.0 | ||
| 264 | 0 | _c20170428 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1476-5608 | ||
| 024 | 7 |
_a10.1038/pcan.2015.58 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRaval, A D | |
| 245 | 0 | 0 |
_aAssociation between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis. _h[electronic resource] |
| 260 |
_bProstate cancer and prostatic diseases _c06 2016 |
||
| 300 |
_a151-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review | ||
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPatient Outcome Assessment |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xepidemiology |
| 700 | 1 | _aThakker, D | |
| 700 | 1 | _aNegi, H | |
| 700 | 1 | _aVyas, A | |
| 700 | 1 | _aKaur, H | |
| 700 | 1 | _aSalkini, M W | |
| 773 | 0 |
_tProstate cancer and prostatic diseases _gvol. 19 _gno. 2 _gp. 151-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/pcan.2015.58 _zAvailable from publisher's website |
| 999 |
_c25644645 _d25644645 |
||